Manipulation of the bacterial flora in inflammatory bowel disease

被引：37

作者：

Marteau, P

Seksik, P

Shanahan, F

机构：

[1] Hop Europeen Georges Pompidou, Dept Gastroenterol, AP HP, F-75908 Paris 15, France

[2] Univ Paris 05, F-75270 Paris 06, France

[3] Natl Univ Ireland Univ Coll Cork, Cork, Ireland

来源：

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY | 2003年 / 17卷 / 01期

关键词：

bacterial flora; inflammatory bowel disease; probiotics; antibiotics; Crohn's disease; ulcerative colitis; pouchitis;

D O I：

10.1053/bega.2002.0344

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

In this chapter we summarize the clinical and experimental data which indicate that bacteria, especially from the endogenous microflora, play a role in the pathogenesis of Crohn's disease, ulcerative colitis and pouchitis. We review the clinical trials, focusing on randomized controlled trials which used antibiotics or probiotics to treat situations of IBD or prevent recurrence, and we discuss the future of this approach.

引用

收藏

页码：47 / 61

页数：15

相关论文

共 93 条

[11]

BURKE DA, 1990, ALIMENT PHARM THERAP, V4, P123

[12] Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: A randomized controlled study vs mesalamine. [J].

Campieri, M ;

Rizzello, F ;

Venturi, A ;

Poggioli, G ;

Ugolini, F ;

Helwig, U ;

Amadini, C ;

Romboli, E ;

Gionchetti, P .

GASTROENTEROLOGY, 2000, 118 (04) :A781-A781

[13]

Casellas F, 1998, INFLAMM BOWEL DIS, V4, P1

[14] CONTROLLED TRIAL OF INTRAVENOUS METRONIDAZOLE AS AN ADJUNCT TO CORTICOSTEROIDS IN SEVERE ULCERATIVE-COLITIS [J].

CHAPMAN, RW ;

SELBY, WS ;

JEWELL, DP .

GUT, 1986, 27 (10) :1210-1212

[15] A controlled trial comparing ciprofloxacin with mesalazine for the treatment of active Crohn's disease [J].

Colombel, JF ;

Lémann, M ;

Cassagnou, M ;

Bouhnik, Y ;

Duclos, B ;

Dupas, JL ;

Notteghem, B ;

Mary, JY .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (03) :674-678

[16] CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice:: Increased T helper cell type 1 response and ability to transfer disease [J].

Cong, YZ ;

Brandwein, SL ;

McCabe, RP ;

Lazenby, A ;

Birkenmeier, EH ;

Sundberg, JP ;

Elson, CO .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (06) :855-864

[17] Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease [J].

Darfeuille-Michaud, A ;

Neut, C ;

Barnich, N ;

Lederman, E ;

Di Martino, P ;

Desreumaux, P ;

Gambiez, L ;

Joly, B ;

Cortot, A ;

Colombel, JF .

GASTROENTEROLOGY, 1998, 115 (06) :1405-1413

[18] METRONIDAZOLE IN TREATMENT OF CHRONIC PROCTITIS - CONTROLLED TRIAL [J].

DAVIES, PS ;

RHODES, J ;

HEATLEY, RV ;

OWEN, E .

GUT, 1977, 18 (08) :680-681

[19] DOUBLE-BLIND CONTROLLED TRIAL OF ORAL VANCOMYCIN AS ADJUNCTIVE TREATMENT IN ACUTE EXACERBATIONS OF IDIOPATHIC COLITIS [J].

DICKINSON, RJ ;

OCONNOR, HJ ;

PINDER, I ;

HAMILTON, I ;

JOHNSTON, D ;

AXON, ATR .

GUT, 1985, 26 (12) :1380-1384

[20]

Donohue DC, 1998, LACTIC ACID BACTERIA, P369

← 1 2 3 4 5 6 7 8 9 10 →